57 related articles for article (PubMed ID: 32354896)
1. Enhanced therapeutic effect of an antiangiogenesis peptide on lung cancer in vivo combined with salmonella VNP20009 carrying a Sox2 shRNA construct.
Zhao C; He J; Cheng H; Zhu Z; Xu H
J Exp Clin Cancer Res; 2016 Jul; 35(1):107. PubMed ID: 27371094
[TBL] [Abstract][Full Text] [Related]
2. SOX2 Regulates lncRNA CCAT1/MicroRNA-185-3p/FOXP3 Axis to Affect the Proliferation and Self-Renewal of Cervical Cancer Stem Cells.
Zhang L; Guo C; Ji T; Chen X
Nanoscale Res Lett; 2021 Jan; 16(1):2. PubMed ID: 33394184
[TBL] [Abstract][Full Text] [Related]
3. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response.
Mirzaei S; Paskeh MDA; Entezari M; Mirmazloomi SR; Hassanpoor A; Aboutalebi M; Rezaei S; Hejazi ES; Kakavand A; Heidari H; Salimimoghadam S; Taheriazam A; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Dec; 156():113860. PubMed ID: 36272267
[TBL] [Abstract][Full Text] [Related]
4. Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies.
Reza MS; Hossen MA; Harun-Or-Roshid M; Siddika MA; Kabir MH; Mollah MNH
Discov Oncol; 2022 Aug; 13(1):79. PubMed ID: 35994213
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.
Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
[TBL] [Abstract][Full Text] [Related]
6. The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway.
Zhang P; Zhao F; Jia K; Liu X
Bioengineered; 2022 Feb; 13(2):2567-2584. PubMed ID: 35015607
[TBL] [Abstract][Full Text] [Related]
7. Cervical Cancer: Emerging Immune Landscape and Treatment.
Guo L; Hua K
Onco Targets Ther; 2020; 13():8037-8047. PubMed ID: 32884290
[TBL] [Abstract][Full Text] [Related]
8. BRM270 targets cancer stem cells and augments chemo-sensitivity in cancer.
Chandimali N; Koh H; Kim J; Lee J; Park YH; Sun HN; Kwon T
Oncol Lett; 2020 Oct; 20(4):103. PubMed ID: 32831922
[TBL] [Abstract][Full Text] [Related]
9. Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer.
Sudhalkar N; Rathod NP; Mathews A; Chopra S; Sriram H; Shrivastava SK; Goda JS
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1144. PubMed ID: 32721115
[TBL] [Abstract][Full Text] [Related]
10. Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review.
Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Pentimalli F; Giordano A; Calleja-Agius J
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563557
[TBL] [Abstract][Full Text] [Related]
11. BRM270 Suppresses Cervical Cancer Stem Cell Characteristics and Progression by Inhibiting SOX2.
Chandimali N; Sun HN; Park YH; Kwon T
In Vivo; 2020; 34(3):1085-1094. PubMed ID: 32354896
[TBL] [Abstract][Full Text] [Related]
12. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK
Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer cells with positive Sox2 expression exhibit the properties of cancer stem cells.
Liu XF; Yang WT; Xu R; Liu JT; Zheng PS
PLoS One; 2014; 9(1):e87092. PubMed ID: 24489842
[TBL] [Abstract][Full Text] [Related]
14. BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells.
Kwon T; Chandimali N; Huynh DL; Zhang JJ; Kim N; Bak Y; Yoon DY; Yu DY; Lee JC; Gera M; Ghosh M; Park YH; Jeong DK
Cell Death Dis; 2018 Feb; 9(2):244. PubMed ID: 29445170
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
